Lysyl oxidase-like-2 promotes tumour angiogenesis and is a potential therapeutic target in angiogenic tumours.
Zaffryar-Eilot S, Marshall D, Voloshin T, Bar-Zion A, Spangler R, Kessler O, Ghermazien H, Brekhman V, Suss-Toby E, Adam D, Shaked Y, Smith V, Neufeld G.
Zaffryar-Eilot S, et al. Among authors: shaked y.
Carcinogenesis. 2013 Oct;34(10):2370-9. doi: 10.1093/carcin/bgt241. Epub 2013 Jul 4.
Carcinogenesis. 2013.
PMID: 23828904